Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION, USP
| Report ID | 168496 |
| Drug Identification Number | 02245248 |
| Brand name | AMIODARONE HYDROCHLORIDE INJECTION |
| Common or Proper name | AMIODARONE HYDROCHLORIDE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | AMIODARONE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3 mL |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-08-02 |
| Actual start date | 2022-12-09 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-12-16 |
| Company comments | On 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-12-16 | French | Compare |
| v7 | 2022-12-16 | English | Compare |
| v6 | 2022-11-24 | French | Compare |
| v5 | 2022-11-24 | English | Compare |
| v4 | 2022-09-12 | French | Compare |
| v3 | 2022-09-12 | English | Compare |
| v2 | 2022-09-01 | French | Compare |
| v1 | 2022-09-01 | English | Compare |
Showing 1 to 8 of 8